[
    [
        {
            "time": "",
            "original_text": "持续发力全球市场 甘李药业赖脯胰岛素在黎巴嫩获批",
            "features": {
                "keywords": [
                    "甘李药业",
                    "赖脯胰岛素",
                    "黎巴嫩",
                    "获批"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "持续发力全球市场 甘李药业赖脯胰岛素在黎巴嫩获批",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "甘李药业：赖脯胰岛素注射液获得黎巴嫩注册批件",
            "features": {
                "keywords": [
                    "甘李药业",
                    "赖脯胰岛素注射液",
                    "黎巴嫩",
                    "注册批件"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "甘李药业：赖脯胰岛素注射液获得黎巴嫩注册批件",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "高瓴资本概念股整体活跃，泰格、金域、凯莱英、恩捷、甘李药业均大涨",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "甘李药业",
                    "泰格",
                    "金域",
                    "凯莱英",
                    "恩捷",
                    "大涨"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴资本概念股整体活跃，泰格、金域、凯莱英、恩捷、甘李药业均大涨",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]